Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Status:
Completed
Trial end date:
2020-05-14
Target enrollment:
Participant gender:
Summary
The main purpose of this Phase 3 study is to evaluate the efficacy of 10 mg and 25 mg
ACT-541468 on objective sleep parameters in subjects with insomnia disorder.